In the diagnostic work up of a patient suspected of having inflammatory bowel disease (IBD),
biomarkers are helpful in prioritizing further examinations, including endoscopy, and/or in …

Autoimmune and antimicrobial antibodies currently play only an adjunctive role in the
diagnosis of inflammatory bowel disease (IBD). Their sensitivity and specificity are not high …

Abstract Crohn's disease (CD), ulcerative colitis (UC), and colitis unclassified, collectively
defined as inflammatory bowel disease (IBD), are the consequence of chronic inflammatory …

Diagnosis and monitoring of inflammatory bowel diseases rely on clinical, endoscopic, and
radiologic parameters. Inflammatory biomarkers have been investigated as a surrogate …

The biomarkers are important in the Inflammatory Bowel Disease (IBD) to gain an objective
measurement of disease activity and severity, as well as prognostic indicator and outcome of …

Fecal and serologic biomarkers can be used in the diagnosis and management of
inflammatory bowel disease (IBD). Fecal markers such as calprotectin and lactoferrin have …

Inflammatory bowel diseases (IBD) are idiopathic, remitting and relapsing diseases causing
chronic inflammation of intestine. Initial diagnosis, assessment of disease activity, and …

Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a
continuous need for proactive monitoring to decide appropriate treatments and follow-up …

The role of biomarkers in the diagnosis of inflammatory bowel disease is not fully
characterized. C-reactive protein has a short half-life and elevates quickly after the onset of …

GVA The gold standard for diagnosing and following patients with inflammatory bowel
disease (IBD) has been endoscopy, which is quite invasive. While a flexible sigmoidoscopy …